STAA STAAR Surgical Company
STAAR Surgical Company (STAA) is expected to report earnings on November 11, 2026, after the market close. The consensus earnings estimate is a loss of $0.03 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +8.7% since its last earnings release on August 12, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About STAAR Surgical Company
STAAR Surgical designs, develops, manufactures and sells implantable lenses for the eye. The Company is a maker of lenses used in corrective surgery, and it also makes lenses for use in surgery that treats cataracts.
Sector
Healthcare
Industry
Medical Appliances/Equipment